Ernexa Therapeutics (ERNAW) Current Taxes (2010 - 2026)

Ernexa Therapeutics (ERNAW) has 15 years of Current Taxes data on file, last reported at $4000.0 in Q1 2026.

• Quarterly Current Taxes fell 63.64% year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4000.0 (down 63.64% YoY) and the FY2025 annual result came in at $3000.0, changed 0.0% from the prior year.
• Current Taxes climbed to $4000.0 in Q1 2026, from $3000.0 in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $18000.0 in Q3 2024 to a low of $2000.0 in Q3 2023.
• A 4-year average of $7615.4 and a median of $7000.0 in 2023 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2024 — Current Taxes surged 800.0% — and 2026, when it tumbled 63.64%.
• Tracing ERNAW's Current Taxes over 4 years: stood at $2000.0 in 2023, then jumped by 50.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025, then jumped by 33.33% to $4000.0 in 2026.
• The last three Current Taxes figures came in at $4000.0 (Q1 2026), $3000.0 (Q4 2025), and $17000.0 (Q3 2025), per Business Quant data.